140 related articles for article (PubMed ID: 24102329)
21. The IBS-36: a new quality of life measure for irritable bowel syndrome.
Groll D; Vanner SJ; Depew WT; DaCosta LR; Simon JB; Groll A; Roblin N; Paterson WG
Am J Gastroenterol; 2002 Apr; 97(4):962-71. PubMed ID: 12003433
[TBL] [Abstract][Full Text] [Related]
22. Quality of life index in autoimmune bullous dermatosis patients.
Penha MÁ; Farat JG; Miot HA; Barraviera SR
An Bras Dermatol; 2015; 90(2):190-4. PubMed ID: 25830988
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of the cough severity index: a severity index for chronic cough related to the upper airway.
Shembel AC; Rosen CA; Zullo TG; Gartner-Schmidt JL
Laryngoscope; 2013 Aug; 123(8):1931-6. PubMed ID: 23737389
[TBL] [Abstract][Full Text] [Related]
24. [Elaboration and validation of a specific quality of life questionnaire for urination urgency in women].
Marquis P; Amarenco G; Sapède C; Josserand F; McCarthy C; Zerbib M; Richard F; Jacquetin B; Villet R; Leriche B; Casanova JM; Conquy S; Zafiropoulos M
Prog Urol; 1997 Feb; 7(1):56-63. PubMed ID: 9116740
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity to change and correlation between the autoimmune bullous disease quality-of-life questionnaires ABQOL and TABQOL, and objective severity scores.
Ferries L; Gillibert A; Duvert-Lehembre S; Corbaux C; Alexandre M; Prost-Squarcioni C; Caux F; Delaporte E; Litrowski N; Boulard C; Murrell DF; Joly P; Hébert V
Br J Dermatol; 2020 Nov; 183(5):944-945. PubMed ID: 32374931
[No Abstract] [Full Text] [Related]
26. The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life.
Taft TH; Kern E; Kwiatek MA; Hirano I; Gonsalves N; Keefer L
Aliment Pharmacol Ther; 2011 Oct; 34(7):790-8. PubMed ID: 21806649
[TBL] [Abstract][Full Text] [Related]
27. Animal models to investigate pathomechanisms and evaluate novel treatments for autoimmune bullous dermatoses.
Iwata H; Bieber K; Hirose M; Ludwig RJ
Curr Pharm Des; 2015; 21(18):2422-39. PubMed ID: 25777758
[TBL] [Abstract][Full Text] [Related]
28. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
Atzori L; Deidda S; Aste N
G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
[TBL] [Abstract][Full Text] [Related]
29. Validation of a disease-specific quality-of-life instrument for acoustic neuroma: the Penn Acoustic Neuroma Quality-of-Life Scale.
Shaffer BT; Cohen MS; Bigelow DC; Ruckenstein MJ
Laryngoscope; 2010 Aug; 120(8):1646-54. PubMed ID: 20641085
[TBL] [Abstract][Full Text] [Related]
30. The development and evaluation of a questionnaire to assess the impact of vulval intraepithelial neoplasia: a questionnaire study.
Lockhart J; Gray NM; Cruickshank ME
BJOG; 2013 Aug; 120(9):1133-42. PubMed ID: 23573981
[TBL] [Abstract][Full Text] [Related]
31. [A preliminary validation of a new French instrument to assess quality of life for caregivers of patients suffering from schizophrenia].
Richieri R; Boyer L; Reine G; Loundou AD; Simeoni MC; Auquier P; Lançon C
Encephale; 2011 Dec; 37(6):425-32. PubMed ID: 22137214
[TBL] [Abstract][Full Text] [Related]
32. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change.
Lindsay RM; Heidenheim PA; Nesrallah G; Garg AX; Suri R;
Clin J Am Soc Nephrol; 2006 Sep; 1(5):952-9. PubMed ID: 17699312
[TBL] [Abstract][Full Text] [Related]
33. The Reliability, Validity and Responsiveness of Two Disease Scores (BPDAI and ABSIS) for Bullous Pemphigoid: Which One to Use?
Wijayanti A; Zhao CY; Boettiger D; Chiang YZ; Ishii N; Hashimoto T; Murrell DF
Acta Derm Venereol; 2017 Jan; 97(1):24-31. PubMed ID: 27244117
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality of life in epidermolysis bullosa: Validation of the Dutch QOLEB questionnaire and assessment in the Dutch population.
Yuen WY; Frew JW; Veerman K; van den Heuvel ER; Murrell DF; Jonkman MF
Acta Derm Venereol; 2014 Jul; 94(4):442-7. PubMed ID: 24337132
[TBL] [Abstract][Full Text] [Related]
35. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany.
Bertram F; Bröcker EB; Zillikens D; Schmidt E
J Dtsch Dermatol Ges; 2009 May; 7(5):434-40. PubMed ID: 19170813
[TBL] [Abstract][Full Text] [Related]
36. Objective scoring systems for disease activity in autoimmune bullous disease.
Sebaratnam DF; Murrell DF
Dermatol Clin; 2011 Jul; 29(3):515-20, xi. PubMed ID: 21605820
[TBL] [Abstract][Full Text] [Related]
37. Quality of life in non-melanoma skin cancer--the skin cancer quality of life (SCQoL) questionnaire.
Vinding GR; Christensen KB; Esmann S; Olesen AB; Jemec GB
Dermatol Surg; 2013 Dec; 39(12):1784-93. PubMed ID: 24237851
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire.
Chan Y; Ching JY; Cheung CM; Tsoi KK; Polder-Verkiel S; Pang SH; Quan WL; Kee KM; Chan FK; Sung JJ; Wu JC
Aliment Pharmacol Ther; 2010 Feb; 31(3):452-60. PubMed ID: 19878152
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of the Bladder Cancer Index: a comprehensive, disease specific measure of health related quality of life in patients with localized bladder cancer.
Gilbert SM; Dunn RL; Hollenbeck BK; Montie JE; Lee CT; Wood DP; Wei JT
J Urol; 2010 May; 183(5):1764-9. PubMed ID: 20299056
[TBL] [Abstract][Full Text] [Related]
40. Lumbar Stiffness Disability Index: pilot testing of consistency, reliability, and validity.
Hart RA; Gundle KR; Pro SL; Marshall LM
Spine J; 2013 Feb; 13(2):157-61. PubMed ID: 23337543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
